US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagonist Therapeutics

51.37

-3.9000-7.06%

Volume:329.23K

Turnover:17.70M

Market Cap:3.18B

PE:59.56

High:55.68

Open:55.50

Low:51.19

Close:55.27

Loading ...

Overview Company News Filings

H.C. Wainwright Reaffirms Their Buy Rating on Protagonist Therapeutics (PTGX)

Protagonist Therapeutics’ Innovative Oral Obesity Candidate PN477 Earns Buy Rating from Analyst Geoff Meacham

Protagonist Therapeutics Unveils PN-477, a Novel Triple Agonist Peptide for Obesity, with Phase I Trials Slated for 2026

Protagonist Therapeutics Stockholders Approve Key Proposals

Protagonist Therapeutics Inc. Held Annual Shareholders Meeting

Protagonist Therapeutics Announces New Oral Obesity Development Candidate with Promising Pre-Clinical Study Results

Protagonist Therapeutics Initiated at Buy by Citigroup

Citigroup Initiates Protagonist Therapeutics at Buy With $72 Price Target

MT Newswires Live

Protagonist Therapeutics initiated with a Buy at Citi

Arturo Molina, Chief Medical Officer, Reports Disposal of Protagonist Therapeutics Inc. Common Shares

For Patients With Rare Blood Cancer, New Drug Offers Relief -- WSJ

Protagonist Therapeutics’ Rusfertide: Promising Efficacy and Financial Upside Drive Buy Recommendation

Protagonist Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

J.P. Morgan Sticks to Its Buy Rating for Protagonist Therapeutics (PTGX)

Protagonist Therapeutics: Promising Future with Rusfertide as a Standard of Care for Polycythemia Vera

Protagonist, Takeda announces Phase 3 VERIFY study met primary endpoint

Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera

Protagonist Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Protagonist Therapeutics: Strategic Partnerships and Innovative Therapies Drive Buy Rating

Johnson & Johnson, Protagonist Therapeutics Say Psoriasis Drug Cleared Skin in Late-Stage Study

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PTGX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTGX\",,,,,undefined,":{"symbol":"PTGX","market":"US","secType":"STK","nameCN":"Protagonist Therapeutics","latestPrice":51.37,"timestamp":1751383065243,"preClose":55.27,"halted":0,"volume":329230,"delay":0,"floatShares":42980407,"shares":61981955,"eps":0.862523,"marketStatus":"Trading","change":-3.9,"latestTime":"07-01 11:17:49 EDT","open":55.5,"high":55.675,"low":51.19,"amount":17701439.4414,"amplitude":0.081147,"askPrice":51.49,"askSize":100,"bidPrice":51.31,"bidSize":15,"shortable":3,"etf":0,"ttmEps":0.862523,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1751400000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":55.27,"preHourTrading":{"tag":"盘前","latestPrice":55.53,"preClose":55.27,"latestTime":"09:29 EDT","volume":988,"amount":54878.793944000005,"timestamp":1751376599999},"postHourTrading":{"tag":"盘后","latestPrice":55,"preClose":55.263,"latestTime":"17:33 EDT","volume":87069,"amount":4824971.6496,"timestamp":1751319200509},"volumeRatio":1.229666,"impliedVol":0.6754,"impliedVolPercentile":0.692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTGX\",,,,,undefined,":{"symbol":"PTGX","floatShares":42980407,"roa":"2.48%","roe":"8.99%","lyrEps":4.469732,"volumeRatio":1.229666,"shares":61981955,"dividePrice":0,"high":55.675,"amplitude":0.081147,"preClose":55.27,"low":51.19,"week52Low":32.5,"pbRate":"4.62","psRate":"15.32","week52High":60.6,"institutionHeld":0,"latestPrice":51.37,"committee":-0.73913,"eps":0.862523,"divideRate":0,"volume":329230,"delay":0,"ttmEps":0.862523,"open":55.5,"prevYearClose":38.6,"prevWeekClose":55.69,"prevMonthClose":55.27,"prevQuarterClose":55.27,"fiveDayClose":53.68,"twentyDayClose":50.15,"sixtyDayClose":46.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTGX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548081970","title":"H.C. Wainwright Reaffirms Their Buy Rating on Protagonist Therapeutics (PTGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2548081970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548081970?lang=en_us&edition=fundamental","pubTime":"2025-07-01 18:37","pubTimestamp":1751366256,"startTime":"0","endTime":"0","summary":"In a report released today, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report), with a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-protagonist-therapeutics-ptgx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-protagonist-therapeutics-ptgx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2548447130","title":"Protagonist Therapeutics’ Innovative Oral Obesity Candidate PN477 Earns Buy Rating from Analyst Geoff Meacham","url":"https://stock-news.laohu8.com/highlight/detail?id=2548447130","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548447130?lang=en_us&edition=fundamental","pubTime":"2025-07-01 08:55","pubTimestamp":1751331310,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Geoff M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-innovative-oral-obesity-candidate-pn477-earns-buy-rating-from-analyst-geoff-meacham-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-innovative-oral-obesity-candidate-pn477-earns-buy-rating-from-analyst-geoff-meacham-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2548017039","title":"Protagonist Therapeutics Unveils PN-477, a Novel Triple Agonist Peptide for Obesity, with Phase I Trials Slated for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2548017039","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548017039?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:05","pubTimestamp":1751313937,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics, Inc. has announced the nomination of PN-477, a potential best-in-class GLP-1, GIP, GCG receptor triple agonist peptide, as a development candidate for the treatment of obesity. The company is developing both an oral version, PN-477o, for once-daily dosing, and a subcutaneous version, PN-477sc, for once-weekly injection. The triple agonist is designed to optimize body weight loss, improve gastrointestinal tolerability, and enhance the fat to lean mass ratio, with the flexibility of oral and injectable routes of administration. IND-enabling studies are currently underway, with the initiation of Phase I clinical trials anticipated in the second quarter of 2026. Protagonist will provide further updates during a webcast and conference call scheduled for later today at 4:30 pm ET. Results from these studies will be presented in the future as they become available.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL4pcYsv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTGX"],"gpt_icon":0},{"id":"2546751891","title":"Protagonist Therapeutics Stockholders Approve Key Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2546751891","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546751891?lang=en_us&edition=fundamental","pubTime":"2025-06-27 04:31","pubTimestamp":1750969889,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics ( ($PTGX) ) has provided an update. At the Annual Meeting, Protagonist Therapeutics‘ stockholders voted on three key propo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/protagonist-therapeutics-stockholders-approve-key-proposals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/protagonist-therapeutics-stockholders-approve-key-proposals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PTGX"],"gpt_icon":0},{"id":"2546540759","title":"Protagonist Therapeutics Inc. Held Annual Shareholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546540759","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546540759?lang=en_us&edition=fundamental","pubTime":"2025-06-27 04:09","pubTimestamp":1750968564,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics Inc. held its Annual Meeting of Stockholders on April 29, 2025. The stockholders voted on three proposals. The election of two Class III director nominees, Harold E. Selick, Ph.D., and Bryan Giraudo, was approved. The compensation of the company's named executive officers was approved on a non-binding, advisory basis. The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. No other matters were submitted for stockholder action.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL2LJKlG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2546784096","title":"Protagonist Therapeutics Announces New Oral Obesity Development Candidate with Promising Pre-Clinical Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2546784096","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546784096?lang=en_us&edition=fundamental","pubTime":"2025-06-26 19:05","pubTimestamp":1750935924,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics Inc. has announced a forthcoming conference call and webcast set to occur on Monday, June 30th, at 4:30 pm ET, during which the company will unveil its new oral obesity development candidate. The event will include a presentation of in vitro and pre-clinical proof-of-concept study results related to the candidate. Interested parties can join the webcast through a provided link, and a replay of the presentation will be accessible on Protagonist's Investor Relations webpage following the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 26, 2025, and is solely responsible for the informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL37mM6b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2544644269","title":"Protagonist Therapeutics Initiated at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2544644269","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544644269?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:53","pubTimestamp":1750161180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PTGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 17, 2025 07:53 ET (11:53 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTGX"],"gpt_icon":0},{"id":"2544965825","title":"Citigroup Initiates Protagonist Therapeutics at Buy With $72 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2544965825","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544965825?lang=en_us&edition=fundamental","pubTime":"2025-06-17 17:59","pubTimestamp":1750154349,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) has an average rating of buy and mean price target of $68.09, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTGX"],"gpt_icon":0},{"id":"2544681659","title":"Protagonist Therapeutics initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2544681659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544681659?lang=en_us&edition=fundamental","pubTime":"2025-06-17 17:30","pubTimestamp":1750152610,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham initiated coverage of Protagonist Therapeutics (PTGX) with a Buy rating and $72 price target The firm cites the potentia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-therapeutics-initiated-with-a-buy-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-therapeutics-initiated-with-a-buy-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2542323558","title":"Arturo Molina, Chief Medical Officer, Reports Disposal of Protagonist Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2542323558","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542323558?lang=en_us&edition=fundamental","pubTime":"2025-06-12 05:41","pubTimestamp":1749678075,"startTime":"0","endTime":"0","summary":"Arturo Molina, MD, the Chief Medical Officer of Protagonist Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL7hdc8D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Arturo Molina, Chief Medical Officer, Reports Disposal of Protagonist Therapeutics Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTGX"],"gpt_icon":0},{"id":"2542320338","title":"For Patients With Rare Blood Cancer, New Drug Offers Relief -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2542320338","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542320338?lang=en_us&edition=fundamental","pubTime":"2025-06-09 22:00","pubTimestamp":1749477600,"startTime":"0","endTime":"0","summary":"For patients with a rare type of blood cancer, treatment might finally be coming out of the Dark Ages.People with the chronic condition polycythemia vera make too many red blood cells, thickening their blood and increasing the risk for clots, heart attacks or strokes. The main treatment consists of regular blood draws -- essentially bloodletting -- to keep the disease in check.But a new drug from Protagonist Therapeutics and Takeda can slow down a patient's production of red blood cells and nearly eliminates the need for phlebotomies, new data show, potentially reducing patients' fatigue and other consequences of routine blood draws.Results from the late-stage trial were presented at the annual American Society of Clinical Oncology conference in Chicago in early June. Some 290 patients who normally require phlebotomies were enrolled, and more than half of them were on chemotherapy or another medication to treat their polycythemia vera. In addition to their normal care, half took a week","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2540773195","title":"Protagonist Therapeutics’ Rusfertide: Promising Efficacy and Financial Upside Drive Buy Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2540773195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540773195?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:35","pubTimestamp":1748946952,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Julian ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-rusfertide-promising-efficacy-and-financial-upside-drive-buy-recommendation-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-rusfertide-promising-efficacy-and-financial-upside-drive-buy-recommendation-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PTGX"],"gpt_icon":0},{"id":"2540361778","title":"Protagonist Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2540361778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540361778?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:08","pubTimestamp":1748945280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PTGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 03, 2025 06:08 ET (10:08 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX"],"gpt_icon":0},{"id":"2540797224","title":"J.P. Morgan Sticks to Its Buy Rating for Protagonist Therapeutics (PTGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540797224","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540797224?lang=en_us&edition=fundamental","pubTime":"2025-06-03 01:45","pubTimestamp":1748886343,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Brian Cheng reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price target of $66.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-buy-rating-for-protagonist-therapeutics-ptgx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-buy-rating-for-protagonist-therapeutics-ptgx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2540792432","title":"Protagonist Therapeutics: Promising Future with Rusfertide as a Standard of Care for Polycythemia Vera","url":"https://stock-news.laohu8.com/highlight/detail?id=2540792432","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540792432?lang=en_us&edition=fundamental","pubTime":"2025-06-03 00:35","pubTimestamp":1748882131,"startTime":"0","endTime":"0","summary":"In a report released today, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report), with a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-promising-future-with-rusfertide-as-a-standard-of-care-for-polycythemia-vera?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-promising-future-with-rusfertide-as-a-standard-of-care-for-polycythemia-vera?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4124","SMP","PTGX","BK4139"],"gpt_icon":0},{"id":"2540573095","title":"Protagonist, Takeda announces Phase 3 VERIFY study met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2540573095","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540573095?lang=en_us&edition=fundamental","pubTime":"2025-06-02 04:05","pubTimestamp":1748808311,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) and Takeda (TAK) announced detailed results from the Phase 3, randomized, placebo-controlled VERIFY study evaluatin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-takeda-announces-phase-3-verify-study-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-takeda-announces-phase-3-verify-study-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX","BK4007","TAK","BK4139"],"gpt_icon":0},{"id":"2540371177","title":"Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera","url":"https://stock-news.laohu8.com/highlight/detail?id=2540371177","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540371177?lang=en_us&edition=fundamental","pubTime":"2025-06-01 20:00","pubTimestamp":1748779200,"startTime":"0","endTime":"0","summary":"Rusfertide plus current standard of care more than doubled clinical response rates across high- and low-risk PV groups, significantly reducing phlebotomy eligibility compared to placebo plus current standard of care, which was the primary endpoint. All key secondary endpoints met with statistical significance, including a nearly three-fold reduction in the proportion of patients requiring phlebotomy and a four-fold improvement in hematocrit control in rusfertide arm compared to placebo arm, as well as improvements in patient-reported outcomes. No serious adverse events considered related to rusfertide were reported. Rusfertide has received Orphan Drug designation and Fast Track designation from the U.S. FDA. \"PV poses significant challenges for patients, including debilitating symptoms and the risk of serious thrombotic events, and hematocrit control is crucial to improving patient outcomes. The VERIFY study demonstrated that treatment with rusfertide controls hematocrit levels in phle","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagonist-takeda-announce-asco-plenary-120000807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1244550577.SGD","LU1718418525.SGD","IE00B7SZLL34.SGD","BK4592","LU0203347892.USD","LU1585245621.USD","IE00B42XCP33.USD","IE00BVYPNW00.USD","IE00BLSP4239.USD","BK4581","LU0466842654.USD","BK4585","LU1023059063.AUD","IE00BLSP4452.SGD","LU2505996681.GBP","IE00BFTCPJ56.SGD","LU0234572021.USD","LU0122379950.USD","IE00BFXG1179.USD","BK4533","LU1057294990.SGD","IE00B19Z3B42.SGD","IE00B3PB1722.GBP","LU1066051225.USD","LU1506573853.SGD","IE00BJJMRZ35.SGD","LU1059921491.USD","LU1674673691.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU1778281490.HKD","BK4588","LU1244550221.USD","LU1280957306.USD","LU1914381329.SGD","LU0345769631.USD","BK4532","LU0795875169.SGD","LU1244550494.USD","BK4504","PTGX","LU1732800096.USD","LU1066051498.USD","LU1066053197.SGD","JNJ","LU1066051811.HKD","LU2430703251.USD","TAK","LU0203345920.USD","LU0985320562.USD"],"gpt_icon":0},{"id":"2536157683","title":"Protagonist Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2536157683","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536157683?lang=en_us&edition=fundamental","pubTime":"2025-05-19 18:44","pubTimestamp":1747651440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PTGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 06:44 ET (10:44 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX"],"gpt_icon":0},{"id":"2536268811","title":"Protagonist Therapeutics: Strategic Partnerships and Innovative Therapies Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2536268811","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536268811?lang=en_us&edition=fundamental","pubTime":"2025-05-19 18:16","pubTimestamp":1747649776,"startTime":"0","endTime":"0","summary":"In a report released today, Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report), with a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-strategic-partnerships-and-innovative-therapies-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-strategic-partnerships-and-innovative-therapies-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2534811424","title":"Johnson & Johnson, Protagonist Therapeutics Say Psoriasis Drug Cleared Skin in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2534811424","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534811424?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:52","pubTimestamp":1746795179,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  and Protagonist Therapeutics  said Friday their jointly developed drug icotrokinra largely met its primary endpoint of significant skin clearance in a phase 3 study of adults and adolescents with moderate or greater plaque psoriasis on high-impact skin areas.The 16-week study showed 57% of patients treated with icotrokinra showed clear or almost clear skin compared with 6% for those receiving a placebo, the companies said.The drug also showed a \"favorable\" safety profile comparable to the placebo, the companies said.Protagonist said it expects to submit a new drug application for icotrokinra with the US Food and Drug Administration this year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","LU0795875086.SGD","BK4139","LU0345770993.USD","LU1267930813.SGD","LU2112291526.USD","LU0058720904.USD","LU1506573853.SGD","IE00BGHQF631.EUR","LU1732800096.USD","LU2129689605.HKD","IE00BJT1NW94.SGD","BK4532","LU1066051811.HKD","LU1894683264.USD","LU0114720955.EUR","LU1074936037.SGD","IE0002270589.USD","IE00BSNM7G36.USD","LU1244550577.SGD","IE00B4R5TH58.HKD","LU1032955483.USD","LU1059921491.USD","LU2430703095.HKD","LU1196500208.SGD","LU2468319806.SGD","IE00B1BXHZ80.USD","LU0795875169.SGD","LU1162221912.USD","LU2505996681.GBP","LU0203345920.USD","LU0792757196.USD","PTGX","SG9999002232.USD","SSI","JNJ","LU0345769631.USD","IE00BJJMRZ35.SGD","SG9999002224.SGD","IE00B3PB1722.GBP","LU0098860793.USD","IE0002141913.USD","LU0640476718.USD","LU1221951129.SGD","IE00BLSP4239.USD","BK4585","LU1778281490.HKD","SG9999001440.SGD","LU2133065610.SGD","LU1221951046.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":118,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"PTGX","fiscalQuarterEnding":"2025/03","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2025-02-21","symbol":"PTGX","fiscalQuarterEnding":"2024/12","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740114000000,"reportTimeType":"pre","actualEps":1.98},{"market":"US","date":"2024-11-07","symbol":"PTGX","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-08-06","symbol":"PTGX","fiscalQuarterEnding":"2024/06","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-05-07","symbol":"PTGX","fiscalQuarterEnding":"2024/03","expectedEps":2.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"post","actualEps":3.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5455,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1733630400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTGX","date":"2025-06-30","current":61.427136,"percent":0.997557,"low":-33.150526,"twenty":-15.384175,"median":-8.272914,"eighty":9.983407,"high":62.177189,"avg":-5.021618,"sd":15.67009,"marketCap":3451775073},"quantilePoints":[{"date":"2020-07-02","current":-7.349526,"twenty":-9.350483,"median":-6.665119,"eighty":-4.765699,"marketCap":611216013},{"date":"2020-07-10","current":-6.745002,"twenty":-9.340032,"median":-6.693722,"eighty":-4.773141,"marketCap":560941344},{"date":"2020-07-17","current":-6.844376,"twenty":-9.31652,"median":-6.693867,"eighty":-4.786321,"marketCap":569205673},{"date":"2020-07-24","current":-6.409615,"twenty":-9.287585,"median":-6.699456,"eighty":-4.791108,"marketCap":533049233},{"date":"2020-07-31","current":-6.51313,"twenty":-9.266951,"median":-6.696733,"eighty":-4.791108,"marketCap":541657909},{"date":"2020-08-07","current":-9.004942,"twenty":-9.227278,"median":-6.701526,"eighty":-4.792704,"marketCap":661061766},{"date":"2020-08-14","current":-7.866789,"twenty":-9.208129,"median":-6.711877,"eighty":-4.798289,"marketCap":577508859},{"date":"2020-08-21","current":-10.519136,"twenty":-9.266951,"median":-6.719534,"eighty":-4.805114,"marketCap":772220259},{"date":"2020-08-28","current":-11.180969,"twenty":-9.350483,"median":-6.73258,"eighty":-4.808526,"marketCap":820806090},{"date":"2020-09-04","current":-10.288497,"twenty":-9.381064,"median":-6.745002,"eighty":-4.811454,"marketCap":755288832},{"date":"2020-09-11","current":-9.972622,"twenty":-9.453356,"median":-6.771156,"eighty":-4.817284,"marketCap":732100140},{"date":"2020-09-18","current":-11.030552,"twenty":-9.502467,"median":-6.779905,"eighty":-4.826262,"marketCap":809763856},{"date":"2020-09-25","current":-10.012733,"twenty":-9.579365,"median":-6.812626,"eighty":-4.827262,"marketCap":735044736},{"date":"2020-10-02","current":-10.283483,"twenty":-9.720678,"median":-6.825377,"eighty":-4.832331,"marketCap":754920758},{"date":"2020-10-09","current":-10.599358,"twenty":-9.834076,"median":-6.831954,"eighty":-4.838822,"marketCap":778109450},{"date":"2020-10-16","current":-10.438913,"twenty":-9.890916,"median":-6.842306,"eighty":-4.842911,"marketCap":766331067},{"date":"2020-10-23","current":-10.002705,"twenty":-9.954868,"median":-6.848516,"eighty":-4.844301,"marketCap":734308587},{"date":"2020-10-30","current":-9.501316,"twenty":-9.954868,"median":-6.855538,"eighty":-4.84986,"marketCap":697501139},{"date":"2020-11-06","current":-12.570131,"twenty":-9.996688,"median":-6.883005,"eighty":-4.85125,"marketCap":814104533},{"date":"2020-11-13","current":-13.119484,"twenty":-10.043212,"median":-6.902064,"eighty":-4.857232,"marketCap":849683350},{"date":"2020-11-20","current":-12.835947,"twenty":-10.069639,"median":-6.909829,"eighty":-4.859892,"marketCap":831320090},{"date":"2020-11-27","current":-14.088234,"twenty":-10.133066,"median":-6.931328,"eighty":-4.863756,"marketCap":912424489},{"date":"2020-12-04","current":-13.23467,"twenty":-10.191167,"median":-6.947788,"eighty":-4.866904,"marketCap":857143424},{"date":"2020-12-11","current":-12.711899,"twenty":-10.248386,"median":-6.951835,"eighty":-4.870704,"marketCap":823286163},{"date":"2020-12-18","current":-14.028485,"twenty":-10.288497,"median":-6.96474,"eighty":-4.870704,"marketCap":908554859},{"date":"2020-12-24","current":-15.775404,"twenty":-10.372775,"median":-6.983794,"eighty":-4.874047,"marketCap":1021694030},{"date":"2020-12-31","current":-13.390827,"twenty":-10.427646,"median":-7.004819,"eighty":-4.876544,"marketCap":867256911},{"date":"2021-01-08","current":-13.716298,"twenty":-10.516128,"median":-7.024491,"eighty":-4.884694,"marketCap":888336072},{"date":"2021-01-15","current":-16.187225,"twenty":-10.554233,"median":-7.0866,"eighty":-4.894853,"marketCap":1048365621},{"date":"2021-01-22","current":-14.852128,"twenty":-10.591336,"median":-7.135435,"eighty":-4.901178,"marketCap":961898042},{"date":"2021-01-29","current":-13.756152,"twenty":-10.619413,"median":-7.158325,"eighty":-4.905297,"marketCap":890917194},{"date":"2021-02-05","current":-14.865412,"twenty":-10.704851,"median":-7.200905,"eighty":-4.911244,"marketCap":962758416},{"date":"2021-02-12","current":-17.362908,"twenty":-10.770833,"median":-7.218551,"eighty":-4.922482,"marketCap":1124508713},{"date":"2021-02-19","current":-17.024152,"twenty":-10.799869,"median":-7.241871,"eighty":-4.92629,"marketCap":1102569178},{"date":"2021-02-26","current":-15.655843,"twenty":-10.882835,"median":-7.247939,"eighty":-4.927782,"marketCap":1013950664},{"date":"2021-03-05","current":-19.342306,"twenty":-10.94369,"median":-7.26205,"eighty":-4.93554,"marketCap":1252704427},{"date":"2021-03-12","current":-20.52997,"twenty":-11.026541,"median":-7.301179,"eighty":-4.944648,"marketCap":1358057548},{"date":"2021-03-19","current":-20.629309,"twenty":-11.096898,"median":-7.312261,"eighty":-4.952769,"marketCap":1364628794},{"date":"2021-03-26","current":-18.020016,"twenty":-11.193984,"median":-7.333401,"eighty":-4.954083,"marketCap":1192024060},{"date":"2021-04-01","current":-17.688887,"twenty":-11.231108,"median":-7.344739,"eighty":-4.954083,"marketCap":1170119906},{"date":"2021-04-09","current":-17.602794,"twenty":-11.41166,"median":-7.360757,"eighty":-4.954083,"marketCap":1164424826},{"date":"2021-04-16","current":-17.63548,"twenty":-11.516633,"median":-7.38668,"eighty":-4.961031,"marketCap":1166586981},{"date":"2021-04-23","current":-19.309356,"twenty":-11.594149,"median":-7.421229,"eighty":-4.962647,"marketCap":1277313881},{"date":"2021-04-30","current":-19.223005,"twenty":-11.691477,"median":-7.444978,"eighty":-4.963904,"marketCap":1271601779},{"date":"2021-05-07","current":-18.301078,"twenty":-11.75763,"median":-7.473566,"eighty":-4.967979,"marketCap":1282319943},{"date":"2021-05-14","current":-19.110139,"twenty":-11.88162,"median":-7.483013,"eighty":-4.967979,"marketCap":1339009208},{"date":"2021-05-21","current":-21.49969,"twenty":-11.947151,"median":-7.506443,"eighty":-4.974928,"marketCap":1506440290},{"date":"2021-05-28","current":-22.020249,"twenty":-11.985902,"median":-7.534801,"eighty":-4.976672,"marketCap":1542914778},{"date":"2021-06-04","current":-21.832095,"twenty":-12.059638,"median":-7.548308,"eighty":-4.980835,"marketCap":1529731228},{"date":"2021-06-11","current":-24.861369,"twenty":-12.389994,"median":-7.587616,"eighty":-4.993626,"marketCap":1741986380},{"date":"2021-06-18","current":-28.48276,"twenty":-12.537035,"median":-7.597798,"eighty":-4.997154,"marketCap":1995730024},{"date":"2021-06-25","current":-29.247308,"twenty":-12.582661,"median":-7.600475,"eighty":-5.001637,"marketCap":2049300361},{"date":"2021-07-02","current":-31.091612,"twenty":-12.701939,"median":-7.651717,"eighty":-5.008279,"marketCap":2178527052},{"date":"2021-07-09","current":-30.9776,"twenty":-12.711899,"median":-7.67129,"eighty":-5.009669,"marketCap":2170538493},{"date":"2021-07-16","current":-30.729458,"twenty":-12.777141,"median":-7.687868,"eighty":-5.009724,"marketCap":2153151629},{"date":"2021-07-23","current":-31.534245,"twenty":-12.933061,"median":-7.7092,"eighty":-5.010215,"marketCap":2209541458},{"date":"2021-07-30","current":-33.150526,"twenty":-13.021304,"median":-7.726424,"eighty":-5.012424,"marketCap":2322791031},{"date":"2021-08-06","current":-28.073213,"twenty":-13.121745,"median":-7.74057,"eighty":-5.014773,"marketCap":2287658067},{"date":"2021-08-13","current":-27.828134,"twenty":-13.235716,"median":-7.773558,"eighty":-5.021266,"marketCap":2267686826},{"date":"2021-08-20","current":-28.720922,"twenty":-13.296243,"median":-7.792145,"eighty":-5.029659,"marketCap":2340439203},{"date":"2021-08-27","current":-27.933168,"twenty":-13.451458,"median":-7.801258,"eighty":-5.035552,"marketCap":2276245929},{"date":"2021-09-03","current":-28.522525,"twenty":-13.634575,"median":-7.822739,"eighty":-5.041631,"marketCap":2324272008},{"date":"2021-09-10","current":-26.305143,"twenty":-13.708328,"median":-7.836668,"eighty":-5.045214,"marketCap":2143579830},{"date":"2021-09-17","current":-10.22913,"twenty":-13.764123,"median":-7.855229,"eighty":-5.050099,"marketCap":833561544},{"date":"2021-09-24","current":-10.976037,"twenty":-13.742868,"median":-7.871118,"eighty":-5.056692,"marketCap":894426278},{"date":"2021-10-01","current":-10.474209,"twenty":-13.720284,"median":-7.892183,"eighty":-5.058339,"marketCap":853532785},{"date":"2021-10-08","current":-10.64343,"twenty":-13.708328,"median":-7.896506,"eighty":-5.059985,"marketCap":867322451},{"date":"2021-10-15","current":-18.071657,"twenty":-13.815403,"median":-7.923511,"eighty":-5.063529,"marketCap":1472641245},{"date":"2021-10-22","current":-18.065822,"twenty":-14.044427,"median":-7.940329,"eighty":-5.065985,"marketCap":1472165740},{"date":"2021-10-29","current":-18.182526,"twenty":-14.108193,"median":-7.965498,"eighty":-5.06708,"marketCap":1481675854},{"date":"2021-11-05","current":-14.975824,"twenty":-14.259226,"median":-7.972706,"eighty":-5.068568,"marketCap":1610350378},{"date":"2021-11-12","current":-16.467193,"twenty":-14.433745,"median":-7.975682,"eighty":-5.071361,"marketCap":1770717221},{"date":"2021-11-19","current":-15.548403,"twenty":-14.860098,"median":-7.984462,"eighty":-5.076877,"marketCap":1671919791},{"date":"2021-11-26","current":-14.762772,"twenty":-15.018434,"median":-8.001658,"eighty":-5.084697,"marketCap":1587440830},{"date":"2021-12-03","current":-14.323351,"twenty":-14.965171,"median":-8.023507,"eighty":-5.090214,"marketCap":1540189885},{"date":"2021-12-10","current":-14.119175,"twenty":-15.004231,"median":-8.049664,"eighty":-5.09948,"marketCap":1518234900},{"date":"2021-12-17","current":-13.475579,"twenty":-14.965171,"median":-8.10968,"eighty":-5.100086,"marketCap":1449028971},{"date":"2021-12-23","current":-15.202193,"twenty":-14.975824,"median":-8.126854,"eighty":-5.100445,"marketCap":1634691774},{"date":"2021-12-31","current":-15.18,"twenty":-15.108982,"median":-8.143408,"eighty":-5.105061,"marketCap":1632305363},{"date":"2022-01-07","current":-15.472947,"twenty":-15.18,"median":-8.170847,"eighty":-5.105061,"marketCap":1663805993},{"date":"2022-01-14","current":-15.961193,"twenty":-15.310445,"median":-8.220609,"eighty":-5.107204,"marketCap":1716307042},{"date":"2022-01-21","current":-13.018403,"twenty":-15.313651,"median":-8.244628,"eighty":-5.11179,"marketCap":1399868897},{"date":"2022-01-28","current":-12.494649,"twenty":-15.270004,"median":-8.259405,"eighty":-5.112936,"marketCap":1343549590},{"date":"2022-02-04","current":-12.534596,"twenty":-15.220835,"median":-8.287857,"eighty":-5.134046,"marketCap":1347845130},{"date":"2022-02-11","current":-12.361491,"twenty":-15.203968,"median":-8.33787,"eighty":-5.153028,"marketCap":1329231121},{"date":"2022-02-18","current":-11.029912,"twenty":-15.202193,"median":-8.359941,"eighty":-5.157029,"marketCap":1186046440},{"date":"2022-02-25","current":-10.870123,"twenty":-15.188877,"median":-8.37967,"eighty":-5.160387,"marketCap":1168864279},{"date":"2022-03-04","current":-9.374147,"twenty":-15.178559,"median":-8.389798,"eighty":-5.170868,"marketCap":1176933522},{"date":"2022-03-11","current":-9.836877,"twenty":-15.098329,"median":-8.39452,"eighty":-5.173647,"marketCap":1235029788},{"date":"2022-03-18","current":-10.480844,"twenty":-14.876842,"median":-8.39452,"eighty":-5.173647,"marketCap":1315880424},{"date":"2022-03-25","current":-9.624793,"twenty":-14.566387,"median":-8.39452,"eighty":-5.173647,"marketCap":1208402332},{"date":"2022-04-01","current":-9.324018,"twenty":-14.424835,"median":-8.39452,"eighty":-5.173647,"marketCap":1170639759},{"date":"2022-04-08","current":-9.70577,"twenty":-14.310208,"median":-8.39452,"eighty":-5.173647,"marketCap":1218569179},{"date":"2022-04-14","current":-7.714908,"twenty":-14.18041,"median":-8.386442,"eighty":-5.173647,"marketCap":968614434},{"date":"2022-04-22","current":-7.312727,"twenty":-14.094448,"median":-8.352792,"eighty":-5.173647,"marketCap":918120248},{"date":"2022-04-29","current":-3.515214,"twenty":-14.033799,"median":-8.271595,"eighty":-5.134046,"marketCap":441338607},{"date":"2022-05-06","current":-3.614961,"twenty":-13.758809,"median":-8.235986,"eighty":-5.104138,"marketCap":442771319},{"date":"2022-05-13","current":-3.499759,"twenty":-13.724069,"median":-8.198163,"eighty":-5.081552,"marketCap":428661025},{"date":"2022-05-20","current":-3.146208,"twenty":-13.724069,"median":-8.198163,"eighty":-5.06468,"marketCap":385357016},{"date":"2022-05-27","current":-3.535512,"twenty":-13.724069,"median":-8.198163,"eighty":-5.046019,"marketCap":433040082},{"date":"2022-06-03","current":-3.654686,"twenty":-13.724069,"median":-8.178259,"eighty":-5.023191,"marketCap":447636938},{"date":"2022-06-10","current":-2.911832,"twenty":-13.724069,"median":-8.178259,"eighty":-5.009669,"marketCap":356649865},{"date":"2022-06-17","current":-3.122373,"twenty":-13.724069,"median":-8.178259,"eighty":-4.980835,"marketCap":382437645},{"date":"2022-06-24","current":-3.607016,"twenty":-13.725196,"median":-8.136316,"eighty":-4.966349,"marketCap":441798196},{"date":"2022-07-01","current":-3.122373,"twenty":-13.725196,"median":-8.111134,"eighty":-4.954083,"marketCap":382437645},{"date":"2022-07-08","current":-3.821531,"twenty":-13.725196,"median":-8.06172,"eighty":-4.930766,"marketCap":468072538},{"date":"2022-07-15","current":-3.757971,"twenty":-13.725196,"median":-7.987171,"eighty":-4.902518,"marketCap":460287547},{"date":"2022-07-22","current":-3.93276,"twenty":-13.725196,"median":-7.971801,"eighty":-4.870704,"marketCap":481696271},{"date":"2022-07-29","current":-3.952623,"twenty":-13.725196,"median":-7.937326,"eighty":-4.854029,"marketCap":484129080},{"date":"2022-08-05","current":-4.239613,"twenty":-13.725196,"median":-7.919184,"eighty":-4.835066,"marketCap":562503419},{"date":"2022-08-12","current":-4.217416,"twenty":-13.725196,"median":-7.896506,"eighty":-4.808704,"marketCap":559558375},{"date":"2022-08-19","current":-3.536711,"twenty":-13.725196,"median":-7.896506,"eighty":-4.791108,"marketCap":469243690},{"date":"2022-08-26","current":-3.451622,"twenty":-13.725196,"median":-7.89352,"eighty":-4.756206,"marketCap":457954354},{"date":"2022-09-02","current":-3.274047,"twenty":-13.725196,"median":-7.821543,"eighty":-4.731245,"marketCap":434394001},{"date":"2022-09-09","current":-3.270347,"twenty":-13.725196,"median":-7.786399,"eighty":-4.687787,"marketCap":433903161},{"date":"2022-09-16","current":-3.092772,"twenty":-13.725196,"median":-7.737759,"eighty":-4.625933,"marketCap":410342808},{"date":"2022-09-23","current":-3.077974,"twenty":-13.725196,"median":-7.700362,"eighty":-4.571699,"marketCap":408379445},{"date":"2022-09-30","current":-3.118668,"twenty":-13.725196,"median":-7.641433,"eighty":-4.473266,"marketCap":413778693},{"date":"2022-10-07","current":-3.074275,"twenty":-13.725196,"median":-7.556602,"eighty":-4.390662,"marketCap":407888605},{"date":"2022-10-14","current":-2.955891,"twenty":-13.725196,"median":-7.482881,"eighty":-4.270343,"marketCap":392181703},{"date":"2022-10-21","current":-3.052078,"twenty":-13.725196,"median":-7.389679,"eighty":-4.207058,"marketCap":404943561},{"date":"2022-10-28","current":-3.174161,"twenty":-13.725196,"median":-7.329698,"eighty":-4.07704,"marketCap":421141303},{"date":"2022-11-04","current":-2.915197,"twenty":-13.725196,"median":-7.297769,"eighty":-4.001892,"marketCap":386782455},{"date":"2022-11-11","current":-3.206636,"twenty":-13.725196,"median":-7.245724,"eighty":-3.947357,"marketCap":417202525},{"date":"2022-11-18","current":-3.055379,"twenty":-13.725196,"median":-7.201344,"eighty":-3.902686,"marketCap":397523160},{"date":"2022-11-25","current":-2.873871,"twenty":-13.725196,"median":-7.138357,"eighty":-3.883416,"marketCap":373907923},{"date":"2022-12-02","current":-3.051598,"twenty":-13.725196,"median":-7.024491,"eighty":-3.813471,"marketCap":397031176},{"date":"2022-12-09","current":-2.862527,"twenty":-13.725196,"median":-6.972734,"eighty":-3.760354,"marketCap":372431971},{"date":"2022-12-16","current":-3.667968,"twenty":-13.725196,"median":-6.94375,"eighty":-3.7496,"marketCap":477224586},{"date":"2022-12-23","current":-3.815443,"twenty":-13.725196,"median":-6.908816,"eighty":-3.718259,"marketCap":496411966},{"date":"2022-12-30","current":-4.125518,"twenty":-13.725196,"median":-6.883005,"eighty":-3.718259,"marketCap":536754664},{"date":"2023-01-06","current":-4.412905,"twenty":-13.725196,"median":-6.84859,"eighty":-3.718259,"marketCap":574145456},{"date":"2023-01-13","current":-4.601976,"twenty":-13.725196,"median":-6.833255,"eighty":-3.718259,"marketCap":598744661},{"date":"2023-01-20","current":-4.409124,"twenty":-13.725196,"median":-6.82294,"eighty":-3.718259,"marketCap":573653472},{"date":"2023-01-27","current":-5.101122,"twenty":-13.725196,"median":-6.776526,"eighty":-3.718259,"marketCap":663686564},{"date":"2023-02-03","current":-5.41876,"twenty":-13.725196,"median":-6.724299,"eighty":-3.718259,"marketCap":705013229},{"date":"2023-02-10","current":-6.507806,"twenty":-13.725196,"median":-6.707737,"eighty":-3.718259,"marketCap":846704653},{"date":"2023-02-17","current":-6.11454,"twenty":-13.725196,"median":-6.693722,"eighty":-3.718259,"marketCap":795538305},{"date":"2023-02-24","current":-6.379238,"twenty":-13.725196,"median":-6.663907,"eighty":-3.718259,"marketCap":829977193},{"date":"2023-03-03","current":-5.940595,"twenty":-13.725196,"median":-6.624925,"eighty":-3.718259,"marketCap":772907036},{"date":"2023-03-10","current":-9.453525,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1229960275},{"date":"2023-03-17","current":-9.023959,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1149589221},{"date":"2023-03-24","current":-8.343741,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1062934191},{"date":"2023-03-31","current":-9.257407,"twenty":-13.724069,"median":-6.653909,"eighty":-3.719583,"marketCap":1179328818},{"date":"2023-04-06","current":-7.686398,"twenty":-13.724069,"median":-6.682278,"eighty":-3.719583,"marketCap":979193321},{"date":"2023-04-14","current":-8.643758,"twenty":-13.725196,"median":-6.707737,"eighty":-3.718259,"marketCap":1101154213},{"date":"2023-04-21","current":-10.23871,"twenty":-13.725196,"median":-6.724299,"eighty":-3.718259,"marketCap":1304340024},{"date":"2023-04-28","current":-10.043772,"twenty":-13.725196,"median":-6.771156,"eighty":-3.718259,"marketCap":1279506203},{"date":"2023-05-05","current":-10.455801,"twenty":-13.725196,"median":-6.812626,"eighty":-3.718259,"marketCap":1331995870},{"date":"2023-05-12","current":-10.095379,"twenty":-13.725196,"median":-6.833255,"eighty":-3.718259,"marketCap":1415250998},{"date":"2023-05-19","current":-10.226064,"twenty":-13.725196,"median":-6.84859,"eighty":-3.718259,"marketCap":1433571400},{"date":"2023-05-26","current":-10.356748,"twenty":-13.726324,"median":-6.891609,"eighty":-3.716934,"marketCap":1451891801},{"date":"2023-06-02","current":-11.226617,"twenty":-13.726324,"median":-6.909323,"eighty":-3.716934,"marketCap":1573836972},{"date":"2023-06-09","current":-11.990305,"twenty":-13.726324,"median":-6.947793,"eighty":-3.716934,"marketCap":1680896817},{"date":"2023-06-16","current":-11.7126,"twenty":-13.727451,"median":-6.972734,"eighty":-3.71561,"marketCap":1641965964},{"date":"2023-06-23","current":-11.247036,"twenty":-13.728579,"median":-7.018276,"eighty":-3.714286,"marketCap":1576699535},{"date":"2023-06-30","current":-11.300127,"twenty":-13.734094,"median":-7.132514,"eighty":-3.713546,"marketCap":1584142198},{"date":"2023-07-07","current":-9.662487,"twenty":-13.734094,"median":-7.200466,"eighty":-3.713546,"marketCap":1354564669},{"date":"2023-07-14","current":-8.737485,"twenty":-13.734094,"median":-7.241871,"eighty":-3.713546,"marketCap":1224890579},{"date":"2023-07-21","current":-8.126943,"twenty":-13.734094,"median":-7.285773,"eighty":-3.713546,"marketCap":1139299954},{"date":"2023-07-28","current":-7.669548,"twenty":-13.734094,"median":-7.312727,"eighty":-3.713546,"marketCap":1075178550},{"date":"2023-08-04","current":-7.763453,"twenty":-13.734094,"median":-7.383681,"eighty":-3.713546,"marketCap":1068336593},{"date":"2023-08-11","current":-7.859608,"twenty":-13.734094,"median":-7.383681,"eighty":-3.713546,"marketCap":1081568549},{"date":"2023-08-18","current":-7.838705,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1078692037},{"date":"2023-08-25","current":-8.06446,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1109758368},{"date":"2023-09-01","current":-8.286034,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1140249396},{"date":"2023-09-08","current":-7.842886,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1079267339},{"date":"2023-09-15","current":-7.525157,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1035544356},{"date":"2023-09-22","current":-7.098731,"twenty":-13.734094,"median":-7.349526,"eighty":-3.713546,"marketCap":976863509},{"date":"2023-09-29","current":-7.161441,"twenty":-13.734094,"median":-7.312727,"eighty":-3.713546,"marketCap":985493045},{"date":"2023-10-06","current":-6.785183,"twenty":-13.734094,"median":-7.297769,"eighty":-3.713546,"marketCap":933715827},{"date":"2023-10-13","current":-6.425648,"twenty":-13.734094,"median":-7.241871,"eighty":-3.713546,"marketCap":884239819},{"date":"2023-10-19","current":-6.212435,"twenty":-13.734094,"median":-7.201344,"eighty":-3.713546,"marketCap":854899396},{"date":"2023-10-27","current":-5.940693,"twenty":-13.756152,"median":-7.161441,"eighty":-3.710587,"marketCap":817504738},{"date":"2023-11-03","current":-6.310619,"twenty":-13.756152,"median":-7.113513,"eighty":-3.710587,"marketCap":886541029},{"date":"2023-11-10","current":-6.174931,"twenty":-13.756152,"median":-7.024491,"eighty":-3.710587,"marketCap":867478954},{"date":"2023-11-17","current":-6.618343,"twenty":-13.756152,"median":-6.973312,"eighty":-3.710587,"marketCap":929771326},{"date":"2023-11-24","current":-7.074073,"twenty":-13.756152,"median":-7.012061,"eighty":-3.710587,"marketCap":993794042},{"date":"2023-12-01","current":-7.476429,"twenty":-13.756152,"median":-7.074073,"eighty":-3.710587,"marketCap":1050318601},{"date":"2023-12-08","current":-8.58496,"twenty":-13.750637,"median":-7.12048,"eighty":-3.711327,"marketCap":1206049531},{"date":"2023-12-15","current":-8.527481,"twenty":-13.750637,"median":-7.155703,"eighty":-3.711327,"marketCap":1197974593},{"date":"2023-12-22","current":-8.872357,"twenty":-13.750637,"median":-7.200905,"eighty":-3.711327,"marketCap":1246424216},{"date":"2023-12-29","current":-9.496419,"twenty":-13.756152,"median":-7.221168,"eighty":-3.710587,"marketCap":1334094961},{"date":"2024-01-05","current":-9.369143,"twenty":-13.758809,"median":-7.255861,"eighty":-3.710382,"marketCap":1316214744},{"date":"2024-01-12","current":-10.026051,"twenty":-13.758809,"median":-7.308825,"eighty":-3.710382,"marketCap":1408499739},{"date":"2024-01-19","current":-9.83719,"twenty":-13.761466,"median":-7.337105,"eighty":-3.710177,"marketCap":1381967803},{"date":"2024-01-26","current":-9.9891,"twenty":-13.758809,"median":-7.381258,"eighty":-3.710382,"marketCap":1403308708},{"date":"2024-02-02","current":-11.709376,"twenty":-13.758809,"median":-7.448718,"eighty":-3.710382,"marketCap":1644980039},{"date":"2024-02-09","current":-10.719909,"twenty":-13.758809,"median":-7.506951,"eighty":-3.710382,"marketCap":1505975765},{"date":"2024-02-16","current":-11.590312,"twenty":-13.758809,"median":-7.588064,"eighty":-3.710382,"marketCap":1628253384},{"date":"2024-02-23","current":-11.368606,"twenty":-13.758809,"median":-7.612358,"eighty":-3.710382,"marketCap":1597107198},{"date":"2024-03-01","current":-22.422829,"twenty":-13.846047,"median":-7.669548,"eighty":-3.710587,"marketCap":1770394439},{"date":"2024-03-08","current":-22.799249,"twenty":-14.088234,"median":-7.709105,"eighty":-3.710587,"marketCap":1800114688},{"date":"2024-03-15","current":-20.924529,"twenty":-14.167973,"median":-7.750912,"eighty":-3.710587,"marketCap":1652096193},{"date":"2024-03-22","current":-20.924529,"twenty":-14.310035,"median":-7.763453,"eighty":-3.710587,"marketCap":1652096193},{"date":"2024-03-28","current":-21.020479,"twenty":-14.42038,"median":-7.763453,"eighty":-3.710587,"marketCap":1659671943},{"date":"2024-04-05","current":-20.407874,"twenty":-14.566387,"median":-7.825595,"eighty":-3.710382,"marketCap":1611303694},{"date":"2024-04-12","current":-20.415255,"twenty":-14.876842,"median":-7.865289,"eighty":-3.710382,"marketCap":1611886444},{"date":"2024-04-19","current":-18.614343,"twenty":-15.098329,"median":-7.910185,"eighty":-3.710382,"marketCap":1469695449},{"date":"2024-04-26","current":-18.201019,"twenty":-15.18,"median":-7.996259,"eighty":-3.710587,"marketCap":1437061450},{"date":"2024-05-03","current":-18.969611,"twenty":-15.310445,"median":-8.088174,"eighty":-3.710587,"marketCap":1497745616},{"date":"2024-05-10","current":10.228214,"twenty":-15.330912,"median":-8.126943,"eighty":-3.694411,"marketCap":1658095799},{"date":"2024-05-17","current":11.556037,"twenty":-15.330912,"median":-8.126943,"eighty":-3.654686,"marketCap":1873349128},{"date":"2024-05-24","current":11.04951,"twenty":-15.330912,"median":-8.126943,"eighty":-3.622906,"marketCap":1791236141},{"date":"2024-05-31","current":10.025604,"twenty":-15.330912,"median":-8.126943,"eighty":-3.603684,"marketCap":1625250605},{"date":"2024-06-07","current":12.30859,"twenty":-15.330912,"median":-8.126943,"eighty":-3.535512,"marketCap":1995345564},{"date":"2024-06-14","current":12.427986,"twenty":-15.332132,"median":-8.135111,"eighty":-3.509824,"marketCap":2014700768},{"date":"2024-06-21","current":11.371517,"twenty":-15.333353,"median":-8.143279,"eighty":-3.48069,"marketCap":1843436540},{"date":"2024-06-28","current":11.534329,"twenty":-15.337014,"median":-8.157491,"eighty":-3.42031,"marketCap":1869830000},{"date":"2024-07-05","current":12.482256,"twenty":-15.337014,"median":-8.157491,"eighty":-3.39613,"marketCap":2023498588},{"date":"2024-07-12","current":12.948984,"twenty":-15.337014,"median":-8.157491,"eighty":-3.360722,"marketCap":2099159840},{"date":"2024-07-15","current":13.06838,"twenty":-15.337014,"median":-8.157491,"eighty":-3.35675,"marketCap":2118515043},{"date":"2024-08-02","current":13.7341,"twenty":-15.368196,"median":-8.262741,"eighty":-3.343328,"marketCap":2226434968},{"date":"2024-08-09","current":12.886266,"twenty":-15.368196,"median":-8.262741,"eighty":-3.288729,"marketCap":2190072470},{"date":"2024-08-16","current":14.068143,"twenty":-15.368196,"median":-8.262741,"eighty":-3.264428,"marketCap":2390937105},{"date":"2024-08-23","current":14.362745,"twenty":-15.368196,"median":-8.262741,"eighty":-3.236958,"marketCap":2441006002},{"date":"2024-08-30","current":14.657348,"twenty":-15.368196,"median":-8.262741,"eighty":-3.21123,"marketCap":2491074899},{"date":"2024-09-06","current":14.563768,"twenty":-15.368196,"median":-8.262741,"eighty":-3.182376,"marketCap":2475170661},{"date":"2024-09-13","current":15.821895,"twenty":-15.368196,"median":-8.262741,"eighty":-3.169466,"marketCap":2688994305},{"date":"2024-09-20","current":15.915474,"twenty":-15.368196,"median":-8.262741,"eighty":-3.139194,"marketCap":2704898543},{"date":"2024-09-27","current":15.572349,"twenty":-15.368196,"median":-8.262741,"eighty":-3.125331,"marketCap":2646583004},{"date":"2024-10-04","current":15.36786,"twenty":-15.368196,"median":-8.262741,"eighty":-3.113634,"marketCap":2611829298},{"date":"2024-10-11","current":15.107917,"twenty":-15.368196,"median":-8.262741,"eighty":-3.099754,"marketCap":2567650860},{"date":"2024-10-18","current":16.296725,"twenty":-15.368196,"median":-8.262741,"eighty":-3.090553,"marketCap":2769693586},{"date":"2024-10-25","current":16.272464,"twenty":-15.368196,"median":-8.262741,"eighty":-3.084958,"marketCap":2765570265},{"date":"2024-10-31","current":16.50468,"twenty":-15.368196,"median":-8.262741,"eighty":-3.065396,"marketCap":2805036337},{"date":"2024-11-08","current":16.414771,"twenty":-15.371747,"median":-8.266026,"eighty":-3.052078,"marketCap":2804447291},{"date":"2024-11-15","current":14.316166,"twenty":-15.371747,"median":-8.266026,"eighty":-3.040652,"marketCap":2445902658},{"date":"2024-11-22","current":14.528955,"twenty":-15.371747,"median":-8.266026,"eighty":-3.023767,"marketCap":2482257449},{"date":"2024-11-29","current":15.278949,"twenty":-15.371747,"median":-8.266026,"eighty":-3.003662,"marketCap":2610393188},{"date":"2024-12-06","current":14.53942,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2484045390},{"date":"2024-12-13","current":14.085935,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2406567966},{"date":"2024-12-20","current":13.792914,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2356505631},{"date":"2024-12-27","current":13.782449,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2354717691},{"date":"2025-01-03","current":13.597567,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2323130741},{"date":"2025-01-10","current":13.123152,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2242077437},{"date":"2025-01-17","current":12.746411,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2177711577},{"date":"2025-01-24","current":13.185942,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2252805080},{"date":"2025-01-31","current":13.646404,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2331474464},{"date":"2025-02-07","current":13.168501,"twenty":-15.375298,"median":-8.269311,"eighty":-2.991095,"marketCap":2249825179},{"date":"2025-02-14","current":13.492917,"twenty":-15.375298,"median":-8.269311,"eighty":-2.95959,"marketCap":2305251336},{"date":"2025-02-21","current":13.426638,"twenty":-15.375298,"median":-8.269311,"eighty":-2.9495,"marketCap":2293927712},{"date":"2025-02-28","current":8.106113,"twenty":-15.375298,"median":-8.269311,"eighty":-2.939639,"marketCap":2230705062},{"date":"2025-03-07","current":8.710614,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2397056485},{"date":"2025-03-14","current":12.246164,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3369997466},{"date":"2025-03-21","current":11.833498,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3256436531},{"date":"2025-03-28","current":11.02824,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3034839248},{"date":"2025-04-04","current":10.372434,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2854369438},{"date":"2025-04-11","current":9.12105,"twenty":-15.375298,"median":-8.269311,"eighty":-2.915804,"marketCap":2510003577},{"date":"2025-04-17","current":10.21629,"twenty":-15.375298,"median":-8.269311,"eighty":-2.915804,"marketCap":2811400436},{"date":"2025-04-25","current":10.00438,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2753085361},{"date":"2025-05-02","current":10.035609,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2761679162},{"date":"2025-05-09","current":48.444601,"twenty":-15.379737,"median":-8.271113,"eighty":-2.915413,"marketCap":2722247463},{"date":"2025-05-16","current":48.98508,"twenty":-15.379737,"median":-8.271113,"eighty":-2.888997,"marketCap":2752618621},{"date":"2025-05-23","current":50.639609,"twenty":-15.379737,"median":-8.271113,"eighty":-2.832786,"marketCap":2845591554},{"date":"2025-05-30","current":52.481651,"twenty":-15.379737,"median":-8.271113,"eighty":8.036964,"marketCap":2949101418},{"date":"2025-06-06","current":59.364491,"twenty":-15.379737,"median":-8.271113,"eighty":8.579007,"marketCap":3335868818},{"date":"2025-06-13","current":62.122038,"twenty":-15.379737,"median":-8.271113,"eighty":9.155848,"marketCap":3490823705},{"date":"2025-06-20","current":59.474792,"twenty":-15.384175,"median":-8.272914,"eighty":9.559592,"marketCap":3342067013},{"date":"2025-06-27","current":60.903202,"twenty":-15.384175,"median":-8.272914,"eighty":9.942216,"marketCap":3422333645},{"date":"2025-06-30","current":61.427136,"twenty":-15.384175,"median":-8.272914,"eighty":9.983407,"marketCap":3451775073}],"updateTime":1751374491924}}}